![Sam Barker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Sam Barker
Former positions of Sam Barker
Companies | Position | Start | End |
---|---|---|---|
BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 2019-12-31 | 2021-07-31 |
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Sam Barker
The University of Exeter | Doctorate Degree |
Statistics
International
United Kingdom | 4 |
Operational
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BIODEXA PHARMACEUTICALS PLC | Health Technology |
Private companies | 1 |
---|---|
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Sam Barker
- Experience